Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bayside, NY
NPI
1952491698
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
22215 Northern Blvd, Ste. Ll-B
Bayside, NY, 11361
Phone (718) 279-4005
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
4,206 services
Medicare patients, 2024
684
Average age 74
Drug cost, 2024
$6.4M
8,958 prescriptions
Company payments, 2025
$146K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vinay Kapoor was code 36415 (venipuncture blood collection), 1,060 times for 473 patients. In total Vinay Kapoor billed 4,206 services in 26 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,060 | 473 | $8.65 | $9,169 |
| 82947 Clinical Chemistry | Office | 1,037 | 382 | $3.85 | $3,992 |
| 99214 Office E&M - Established | Office | 1,012 | 389 | $106.86 | $108K |
| 99213 Office E&M - Established | Office | 505 | 294 | $75.35 | $38K |
| 76536 Ultrasound - Nonspecific | Office | 100 | 92 | $100.30 | $10K |
| 99204 Office E&M - New | Office | 55 | 55 | $138.88 | $7,638 |
| 93922 Duplex Scan - Extremity Arteries | Office | 52 | 52 | $74.10 | $3,853 |
| 95921 Electrical Nerve Conductivity | Office | 48 | 48 | $79.70 | $3,826 |
| 99212 Office E&M - Established | Office | 47 | 38 | $42.23 | $1,985 |
| 99203 Office E&M - New | Office | 46 | 46 | $91.29 | $4,199 |
| 95923 Electrical Nerve Conductivity | Office | 45 | 45 | $113.44 | $5,105 |
| 96372 Injection Administration | Office | 35 | 18 | $11.65 | $408 |
| 99215 Office E&M - Established | Office | 34 | 34 | $124.38 | $4,229 |
| 95251 Test - Miscellaneous | Office | 24 | 19 | $28.89 | $693 |
| G0008 Administration of influenza virus vaccine | Office | 19 | 19 | $36.42 | $692 |
By year: 2022 $182K for 3,845 services; 2023 $215K for 4,400 services; 2024 $206K for 4,206 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,060 | 473 | $8.65 | $9,169 |
| 82947 Clinical Chemistry | 1,037 | 382 | $3.85 | $3,992 |
Medicare prescription drug claims, 2024
In 2024, the drug Vinay Kapoor prescribed most often to Medicare patients was Ozempic (Semaglutide), with 994 prescriptions and refills. In total Vinay Kapoor wrote 8,958 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 994 | 2,009 | 243 | $1.9M |
| Levothyroxine Sodium Generic | 596 | 1,659 | 176 | $9,446 |
| Farxiga Dapagliflozin Propanediol | 394 | 908 | 109 | $496K |
| Tresiba Flextouch U-200 Insulin Degludec | 388 | 916 | 110 | $414K |
| Metformin Hcl Generic | 379 | 994 | 131 | $3,715 |
| Rosuvastatin Calcium Generic | 326 | 926 | 117 | $4,626 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 324 | 697 | 79 | $384K |
| Jardiance Empagliflozin | 315 | 699 | 108 | $395K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 280 | 775 | 132 | $36K |
| Atorvastatin Calcium Generic | 261 | 746 | 77 | $2,429 |
| Janumet Sitagliptin Phos/Metformin Hcl | 254 | 580 | 68 | $306K |
| Synthroid Levothyroxine Sodium | 226 | 616 | 61 | $19K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 191 | 431 | 69 | $28K |
| Novolog Flexpen Insulin Aspart | 132 | 326 | 56 | $45K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 132 | 301 | 45 | $80K |
Brand drugs: 5,182 claims; generic drugs: 3,040 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vinay Kapoor $146K ($146K in general payments such as food, travel and fees) from 26 companies. The largest payer was Novo Nordisk Inc with $38K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 48 | $38K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 24 | $17K |
| Sanofi-Aventis U.S. LLC SNY | 17 | $17K |
| Dexcom, Inc. DXCM | 15 | $16K |
| Amgen Inc. AMGN | 40 | $14K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $10K |
| Xeris Pharmaceuticals, Inc. | 21 | $9,992 |
| CeQur Corporation | 3 | $9,000 |
| Lilly USA, LLC LLY | 8 | $5,138 |
| Abbott Laboratories ABT | 9 | $4,637 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.